Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846911 | 12784691 | 1 | I | 20160316 | 20160919 | 20160927 | 20160927 | EXP | US-BAXTER-2016BAX049056 | BAXTER | 61.32 | YR | F | Y | 0.00000 | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846911 | 12784691 | 1 | PS | CYCLOPHOSPHAMIDE FOR INJECTION, USP | CYCLOPHOSPHAMIDE | 1 | Unknown | D | 40745 | POWDER FOR SOLUTION FOR INJECTION | |||||||||
| 127846911 | 12784691 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | D | 0 | ||||||||||
| 127846911 | 12784691 | 3 | SS | TAXOL | PACLITAXEL | 1 | Unknown | D | 0 | ||||||||||
| 127846911 | 12784691 | 4 | SS | FASLODEX | FULVESTRANT | 1 | Unknown | D | 0 | /month | |||||||||
| 127846911 | 12784691 | 5 | SS | XGEVA | DENOSUMAB | 1 | Unknown | D | 0 | /month | |||||||||
| 127846911 | 12784691 | 6 | SS | XGEVA | DENOSUMAB | 1 | Unknown | D | 0 | ||||||||||
| 127846911 | 12784691 | 7 | SS | ARIMIDEX | ANASTROZOLE | 1 | Unknown | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127846911 | 12784691 | 1 | Invasive ductal breast carcinoma |
| 127846911 | 12784691 | 2 | Invasive ductal breast carcinoma |
| 127846911 | 12784691 | 3 | Invasive ductal breast carcinoma |
| 127846911 | 12784691 | 4 | Breast cancer metastatic |
| 127846911 | 12784691 | 5 | Breast cancer metastatic |
| 127846911 | 12784691 | 7 | Invasive ductal breast carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127846911 | 12784691 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127846911 | 12784691 | Back pain | |
| 127846911 | 12784691 | Blood count abnormal | |
| 127846911 | 12784691 | Breast cancer metastatic | |
| 127846911 | 12784691 | Chills | |
| 127846911 | 12784691 | Cough | |
| 127846911 | 12784691 | Disease progression | |
| 127846911 | 12784691 | Hot flush | |
| 127846911 | 12784691 | Hyperhidrosis | |
| 127846911 | 12784691 | Lymphoedema | |
| 127846911 | 12784691 | Metastases to bone | |
| 127846911 | 12784691 | Oropharyngeal pain | |
| 127846911 | 12784691 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127846911 | 12784691 | 4 | 201311 | 0 | ||
| 127846911 | 12784691 | 5 | 201311 | 0 | ||
| 127846911 | 12784691 | 6 | 201603 | 0 | ||
| 127846911 | 12784691 | 7 | 200910 | 0 |